Index - P/E - EPS (ttm) -1.06 Insider Own 26.14% Shs Outstand 57.91M Perf Week -16.15%
Market Cap 193.46M Forward P/E - EPS next Y -1.42 Insider Trans -0.22% Shs Float 44.37M Perf Month 1.58%
Income -55.94M PEG - EPS next Q -0.28 Inst Own 63.81% Short Float 1.84% Perf Quarter -20.88%
Sales 0.00M P/S - EPS this Y -7.39% Inst Trans 4.20% Short Ratio 2.75 Perf Half Y 35.86%
Book/sh 4.36 P/B 0.74 EPS next Y -22.02% ROA -22.89% Short Interest 0.82M Perf Year -33.61%
Cash/sh 4.20 P/C 0.77 EPS next 5Y -0.20% ROE -25.36% 52W Range 1.81 - 11.31 Perf YTD -16.15%
Dividend Est. - P/FCF - EPS past 5Y -54.03% ROI -19.12% 52W High -71.53% Beta 0.21
Dividend TTM - Quick Ratio 30.20 Sales past 5Y -28.84% Gross Margin - 52W Low 77.89% ATR (14) 0.23
Dividend Ex-Date - Current Ratio 30.20 EPS Y/Y TTM 4.53% Oper. Margin 0.00% RSI (14) 39.82 Volatility 7.16% 6.54%
Employees 52 Debt/Eq 0.12 Sales Y/Y TTM - Profit Margin - Recom 1.00 Target Price 12.80
Option/Short Yes / Yes LT Debt/Eq 0.12 EPS Q/Q 9.76% Payout - Rel Volume 0.71 Prev Close 3.40
Sales Surprise - EPS Surprise 4.18% Sales Q/Q - Earnings May 14 BMO Avg Volume 296.59K Price 3.22
SMA20 -8.20% SMA50 -11.71% SMA200 -15.86% Trades
Volume 190,362 Change -5.29%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-12-23 Initiated Deutsche Bank
Buy
$8
Jul-20-23 Resumed BofA Securities
Buy
$9 → $14
May-18-23 Initiated Cantor Fitzgerald
Overweight
$13
Jul-15-22 Initiated BTIG Research
Buy
$15
Jun-30-22 Initiated H.C. Wainwright
Buy
$15
Jan-21-22 Upgrade BofA Securities
Neutral → Buy
$16 → $14
Jul-26-21 Initiated UBS
Buy
$27
Jul-26-21 Initiated Stifel
Buy
$27
Jul-26-21 Initiated Credit Suisse
Outperform
$26
Jul-26-21 Initiated BofA Securities
Neutral
$20
May-15-24 03:00AM
02:06AM
(Thomson Reuters StreetEvents)
May-14-24 11:53AM
07:00AM
May-13-24 04:00PM
10:15AM
Loading…
10:15AM
May-08-24 05:47PM
03:32PM
08:00AM
May-07-24 04:00PM
Apr-19-24 12:13PM
Apr-16-24 08:00AM
Apr-08-24 05:38PM
Apr-04-24 02:12PM
08:00AM
08:38AM
Loading…
Apr-03-24 08:38AM
Mar-28-24 12:00PM
Mar-27-24 09:46AM
Mar-26-24 09:20PM
(Thomson Reuters StreetEvents) -11.76%
11:52AM
07:00AM
Mar-21-24 10:41AM
08:00AM
Mar-19-24 04:00PM
Mar-18-24 10:31AM
Mar-12-24 04:00PM
Mar-08-24 08:50AM
Feb-29-24 09:40AM
Feb-21-24 08:00AM
Feb-01-24 07:00AM
02:14PM
Loading…
Jan-30-24 02:14PM
Jan-24-24 01:58PM
Jan-04-24 04:15PM
Nov-14-23 08:53AM
Nov-13-23 11:08PM
(Thomson Reuters StreetEvents) +6.84%
10:54AM
09:31AM
07:00AM
07:00AM
Nov-07-23 04:01PM
11:22AM
(Thomson Reuters StreetEvents)
Nov-06-23 04:01PM
07:30AM
Nov-02-23 04:00PM
Oct-27-23 09:25AM
Oct-04-23 08:00AM
Sep-19-23 04:00PM
Sep-06-23 04:00PM
Aug-08-23 10:21PM
(Thomson Reuters StreetEvents)
07:00AM
Aug-01-23 04:00PM
Jul-25-23 01:47PM
Jul-18-23 10:31PM
11:32AM
Jul-17-23 04:53PM
07:00AM
Jul-16-23 03:00AM
02:00AM
Jul-03-23 05:13PM
Jun-28-23 06:30AM
Jun-13-23 07:00AM
May-16-23 12:41PM
May-09-23 07:00AM
May-04-23 04:01PM
May-02-23 04:01PM
Apr-09-23 08:57AM
Mar-29-23 07:30AM
Mar-28-23 08:00AM
Mar-27-23 07:00AM
Mar-22-23 04:01PM
Mar-20-23 04:01PM
Mar-08-23 04:01PM
Feb-15-23 12:07PM
Feb-13-23 08:00AM
Jan-06-23 09:40AM
Jan-04-23 08:00AM
Dec-29-22 06:02AM
Nov-14-22 04:01PM
Nov-09-22 04:01PM
Nov-07-22 04:01PM
Nov-01-22 08:00AM
Oct-24-22 08:00AM
Sep-08-22 12:44PM
Aug-15-22 11:00PM
04:05PM
Aug-08-22 04:15PM
Aug-01-22 10:30AM
Jul-26-22 04:15PM
Jun-08-22 08:00AM
May-16-22 10:00PM
04:05PM
May-11-22 05:08PM
Apr-27-22 08:00AM
Apr-02-22 12:00AM
Apr-01-22 05:01PM
Mar-28-22 04:05PM
Mar-16-22 04:15PM
Dec-30-21 04:16AM
Nov-25-21 07:35AM
Nov-15-21 08:00AM
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Charlottesville, VA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
OConnell Daniel Joseph President and CEO Jan 19 '24 Sale 3.47 15,200 52,753 502,485 Jan 19 07:07 PM Meisner Derek M Chief Legal Officer & Corp Sec Jan 19 '24 Sale 3.48 8,933 31,048 108,867 Jan 19 07:06 PM Zuga Matt CFO & Chief Business Officer Jan 18 '24 Sale 3.71 4,242 15,717 211,445 Jan 19 07:05 PM Siemers Eric Chief Medical Officer Jan 18 '24 Sale 3.71 3,124 11,604 117,576 Jan 19 07:05 PM Barton Russell Chief Operating Officer Jan 18 '24 Sale 3.73 2,833 10,555 96,867 Jan 19 07:04 PM Ives Jeffrey L. Director Aug 17 '23 Option Exercise 0.75 41,949 31,519 39,149 Aug 18 06:31 PM Ives Jeffrey L. Director Aug 17 '23 Sale 6.49 41,949 272,334 0 Aug 18 06:31 PM RA CAPITAL MANAGEMENT, L.P. Director Jul 21 '23 Buy 7.75 5,161,290 39,999,998 13,043,179 Jul 25 04:30 PM
Index RUT P/E - EPS (ttm) -0.70 Insider Own 29.90% Shs Outstand 167.43M Perf Week 5.04%
Market Cap 158.80M Forward P/E - EPS next Y -0.46 Insider Trans -0.37% Shs Float 117.73M Perf Month -18.83%
Income -128.91M PEG - EPS next Q 0.01 Inst Own 39.63% Short Float 10.37% Perf Quarter -5.02%
Sales 0.00M P/S - EPS this Y 4.26% Inst Trans 67.22% Short Ratio 3.65 Perf Half Y 18.11%
Book/sh 0.01 P/B 153.26 EPS next Y 15.71% ROA -108.98% Short Interest 12.21M Perf Year -52.96%
Cash/sh 0.48 P/C 1.96 EPS next 5Y - ROE -489.12% 52W Range 0.57 - 2.58 Perf YTD 12.77%
Dividend Est. - P/FCF - EPS past 5Y 73.95% ROI -221.58% 52W High -63.28% Beta 0.37
Dividend TTM - Quick Ratio 3.71 Sales past 5Y -20.00% Gross Margin - 52W Low 65.23% ATR (14) 0.09
Dividend Ex-Date - Current Ratio 3.71 EPS Y/Y TTM 46.99% Oper. Margin 0.00% RSI (14) 40.95 Volatility 7.02% 9.85%
Employees 93 Debt/Eq 56.03 Sales Y/Y TTM - Profit Margin - Recom 1.29 Target Price 4.12
Option/Short Yes / Yes LT Debt/Eq 54.94 EPS Q/Q -57.23% Payout - Rel Volume 0.30 Prev Close 0.90
Sales Surprise - EPS Surprise -68.50% Sales Q/Q - Earnings May 07 BMO Avg Volume 3.35M Price 0.95
SMA20 -6.94% SMA50 -19.18% SMA200 -3.79% Trades
Volume 908,112 Change 4.71%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-12-23 Downgrade B. Riley Securities
Buy → Neutral
$3 → $1
Aug-30-23 Resumed B. Riley Securities
Buy
$3
Dec-22-22 Initiated Cantor Fitzgerald
Overweight
$3
Dec-12-22 Initiated Piper Sandler
Overweight
$3
Dec-23-19 Initiated Oppenheimer
Outperform
$20
Dec-18-19 Initiated ROTH Capital
Buy
$20
Dec-09-19 Upgrade Citigroup
Neutral → Buy
$16 → $20
Dec-05-19 Initiated B. Riley FBR
Buy
Jun-07-19 Initiated Stifel
Buy
$27
Jun-05-19 Initiated Cowen
Outperform
May-13-24 08:00AM
May-09-24 03:59PM
11:52AM
07:29AM
06:30AM
11:10AM
Loading…
May-08-24 11:10AM
03:14AM
May-07-24 10:54AM
06:07AM
(Associated Press Finance)
06:01AM
May-01-24 04:05PM
Apr-30-24 09:32AM
08:00AM
Apr-29-24 11:19AM
06:47AM
06:30AM
Loading…
06:30AM
Apr-02-24 04:05PM
Apr-01-24 08:00AM
Mar-22-24 12:47PM
Mar-21-24 10:09PM
(Thomson Reuters StreetEvents) +28.43%
10:53AM
09:11AM
06:01AM
Mar-12-24 08:00AM
Mar-01-24 04:05PM
Feb-01-24 04:05PM
Dec-09-23 12:00PM
Dec-04-23 04:05PM
Nov-10-23 03:46PM
08:00AM
01:48AM
Loading…
01:48AM
(Thomson Reuters StreetEvents)
Nov-09-23 09:29AM
06:01AM
Nov-02-23 08:00AM
Nov-01-23 04:05PM
Oct-31-23 08:00AM
Oct-18-23 08:00AM
Oct-02-23 04:05PM
Sep-19-23 08:00AM
Sep-06-23 08:00AM
Sep-05-23 08:00AM
Sep-01-23 04:05PM
Aug-15-23 10:53AM
Aug-10-23 06:38AM
(Associated Press Finance) -35.98%
06:05AM
Aug-08-23 04:05PM
Aug-03-23 08:00AM
Aug-02-23 08:01AM
Jun-30-23 04:05PM
Jun-14-23 06:26AM
(Zacks Small Cap Research)
Jun-13-23 08:00AM
Jun-02-23 04:05PM
May-16-23 04:01PM
08:30AM
May-15-23 04:44AM
May-04-23 06:12AM
06:05AM
Apr-26-23 12:32PM
(Simply Wall St.) +11.11%
08:01AM
Apr-12-23 08:00AM
Apr-04-23 04:05PM
Mar-24-23 07:36AM
Mar-21-23 06:05AM
Mar-07-23 08:01AM
Mar-02-23 04:05PM
Jan-31-23 12:00PM
Dec-12-22 08:30AM
Dec-07-22 08:43AM
Dec-06-22 06:26PM
Nov-30-22 08:05AM
Nov-29-22 04:01PM
Nov-17-22 09:51AM
Nov-08-22 08:00AM
Nov-04-22 04:05PM
Nov-03-22 06:05AM
Oct-26-22 08:00AM
Oct-20-22 08:00AM
Sep-27-22 10:49AM
07:50AM
Aug-31-22 08:30AM
Aug-18-22 12:00PM
Aug-08-22 04:05PM
Aug-04-22 07:05AM
Jul-26-22 04:05PM
Jul-21-22 02:46PM
(American City Business Journals) +9.65%
07:58AM
Jul-20-22 04:10PM
Jul-01-22 04:30PM
Jun-30-22 07:52PM
Jun-23-22 07:00AM
May-16-22 06:05AM
May-12-22 07:15AM
06:05AM
May-03-22 06:05AM
May-02-22 04:05PM
Apr-08-22 01:05PM
Apr-04-22 08:05AM
Apr-01-22 04:05PM
Mar-17-22 06:05AM
Mar-08-22 08:00AM
X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Mostafa Adam S. Chief Financial Officer Mar 11 '24 Sale 0.88 52,500 46,347 0 Mar 11 05:19 PM Ragan Paula President and CEO Mar 11 '24 Sale 0.88 49,678 43,856 765,068 Mar 11 05:20 PM DiBiase Mary Chief Operating Officer Mar 11 '24 Sale 0.88 15,409 13,591 291,752 Mar 11 05:19 PM Taveras Arthur Chief Scientific Officer Mar 11 '24 Sale 0.88 14,235 12,552 234,301 Mar 11 05:20 PM Mostafa Adam S. Chief Financial Officer Feb 12 '24 Sale 1.01 27,721 27,973 52,500 Feb 12 05:03 PM Ragan Paula President and CEO Feb 12 '24 Sale 1.01 21,695 21,892 814,746 Feb 12 05:05 PM DiBiase Mary Chief Operating Officer Feb 12 '24 Sale 1.01 3,683 3,709 307,161 Feb 12 05:23 PM Taveras Arthur Chief Scientific Officer Feb 12 '24 Sale 1.01 787 793 248,536 Feb 12 05:23 PM Ragan Paula President and CEO Nov 03 '23 Sale 0.90 39,906 35,915 836,441 Nov 03 05:26 PM Mostafa Adam S. Chief Financial Officer Nov 01 '23 Sale 0.73 230,645 168,371 80,221 Nov 03 04:42 PM Ragan Paula President and CEO Nov 01 '23 Sale 0.73 199,531 145,658 876,347 Nov 03 05:26 PM DiBiase Mary Chief Operating Officer Nov 01 '23 Sale 0.73 67,695 49,417 310,844 Nov 03 04:40 PM Taveras Arthur Chief Scientific Officer Nov 01 '23 Sale 0.73 67,695 49,417 249,323 Nov 03 04:39 PM Baldry Mark Chief Commercial Officer Nov 01 '23 Sale 0.73 10,257 7,488 24,690 Nov 03 04:39 PM DiBiase Mary Chief Operating Officer Sep 08 '23 Sale 1.25 2,642 3,300 147,894 Sep 12 04:04 PM WYZGA MICHAEL S Director Aug 18 '23 Buy 1.20 25,000 29,875 76,667 Aug 22 04:09 PM Stewart Murray Interim Chief Medical Officer Aug 10 '23 Sale 1.06 130,056 137,859 146,504 Aug 11 07:26 PM Mostafa Adam S. Chief Financial Officer Jun 30 '23 Sale 1.89 2,641 4,991 80,221 Jul 05 04:04 PM DiBiase Mary Chief Operating Officer Jun 30 '23 Sale 1.89 464 877 150,536 Jul 05 04:05 PM Ragan Paula President and CEO Jun 23 '23 Sale 1.92 6,724 12,910 543,797 Jun 26 04:11 PM Mostafa Adam S. Chief Financial Officer Jun 23 '23 Sale 1.93 5,417 10,455 82,862 Jun 26 04:13 PM DiBiase Mary Chief Operating Officer Jun 23 '23 Sale 1.93 857 1,654 151,000 Jun 26 04:15 PM Ragan Paula President and CEO Jun 15 '23 Sale 2.23 6,724 14,995 550,521 Jun 16 04:15 PM Mostafa Adam S. Chief Financial Officer Jun 15 '23 Sale 2.22 5,417 12,026 88,279 Jun 16 04:17 PM DiBiase Mary Chief Operating Officer Jun 15 '23 Sale 2.23 857 1,911 151,857 Jun 16 04:24 PM Ragan Paula President and CEO May 31 '23 Sale 1.95 6,292 12,269 557,245 May 31 05:05 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
